Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04760301

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

Local Tranexamic Acid During Vaginal Hysterectomy to Reduce Blood Loss

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
Female
Age
20 Years – 90 Years
Healthy volunteers
Accepted

Summary

Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation

Detailed description

This randomized control trial will investigate whether local tranexamic acid is efficient for decreasing bleeding during vaginal hysterectomy. The investigators will randomize local placebo (saline) vs. local 1 gr tranexamic acid; local 1gr tranexamic acid diluted in 10 ml saline and local 10 ml saline at the beginning of surgery.

Conditions

Interventions

TypeNameDescription
DRUGlocal tranexamic acid injectionlocal tranexamic acid injection to cervix- 1 g tranexamic acid diluted in 10 ml saline
OTHERlocal normal saline injection to cervixlocal normal saline injection to the cervix- 20 ml saline

Timeline

Start date
2021-02-16
Primary completion
2025-07-01
Completion
2026-06-01
First posted
2021-02-18
Last updated
2025-05-06

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT04760301. Inclusion in this directory is not an endorsement.

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss (NCT04760301) · Clinical Trials Directory